MAPT and Alzheimer disease: Although the pathogenesis of AD is complex and not fully understood, several important clinical hallmarks, such as low level of acetylcholine (ACh), beta-amyloid (Aβ) protein aggregation, and tau (τ)-protein phosphorylation, are involved in the occurrence and development of AD [6].